Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$55.15 USD
-0.25 (-0.45%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $55.16 +0.01 (0.02%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: AMC |
6/2024 | $0.78 | 0.00% |
Earnings Summary
For their last quarter, Halozyme Therapeutics (HALO) reported earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.69 per share. This reflects a positive earnings surprise of 14.49%. Look out for HALO's next earnings release on August 06, 2024. For the next earning release, we expect the company to report earnings of $0.78 per share, reflecting a year-over-year increase of 5.41%.
Earnings History
Price & Consensus
Zacks News for HALO
Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term
HALO: What are Zacks experts saying now?
Zacks Private Portfolio Services